Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DNA hypermethylation as a chemotherapy target.
Ren J, Singh BN, Huang Q, Li Z, Gao Y, Mishra P, Hwa YL, Li J, Dowdy SC, Jiang SW. Ren J, et al. Among authors: hwa yl. Cell Signal. 2011 Jul;23(7):1082-93. doi: 10.1016/j.cellsig.2011.02.003. Epub 2011 Feb 21. Cell Signal. 2011. PMID: 21345368 Review.
Primary adenomyoepithelioma of tonsil.
Ren J, Song L, Dang Q, Zhang X, Jiang SW, Zhang G, Wang N, Liu Z, Wang J, Hwa YL, Li Z, Zhao X, Liu Y. Ren J, et al. Among authors: hwa yl. Head Neck Oncol. 2010 Mar 31;2:7. doi: 10.1186/1758-3284-2-7. Head Neck Oncol. 2010. PMID: 20356364 Free PMC article. Review.
Tumor markers for early detection of ovarian cancer.
Ren J, Cai H, Li Y, Zhang X, Liu Z, Wang JS, Hwa YL, Zhang Y, Yang Y, Li Y, Jiang SW. Ren J, et al. Among authors: hwa yl. Expert Rev Mol Diagn. 2010 Sep;10(6):787-98. doi: 10.1586/erm.10.39. Expert Rev Mol Diagn. 2010. PMID: 20843202 Review.
Nonhistone protein acetylation as cancer therapy targets.
Singh BN, Zhang G, Hwa YL, Li J, Dowdy SC, Jiang SW. Singh BN, et al. Among authors: hwa yl. Expert Rev Anticancer Ther. 2010 Jun;10(6):935-54. doi: 10.1586/era.10.62. Expert Rev Anticancer Ther. 2010. PMID: 20553216 Free PMC article. Review.
Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment.
Kourelis TV, Buadi FK, Gertz MA, Lacy MQ, Kumar SK, Kapoor P, Go RS, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Leung N, Hwa YL, Gonsalves W, Kyle RA, Dispenzieri A. Kourelis TV, et al. Among authors: hwa yl. Leukemia. 2016 May;30(5):1079-85. doi: 10.1038/leu.2015.344. Epub 2015 Dec 16. Leukemia. 2016. PMID: 26669974
Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells.
Gonsalves WI, Jevremovic D, Nandakumar B, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Go RS, Siddiqui MA, Kyle RA, Gertz MA, Rajkumar SV, Kumar SK. Gonsalves WI, et al. Among authors: hwa yl. Am J Hematol. 2020 Mar;95(3):310-315. doi: 10.1002/ajh.25709. Epub 2020 Jan 8. Am J Hematol. 2020. PMID: 31867775 Free PMC article. Clinical Trial.
Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma.
Mellors PW, Binder M, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Hayman SR, Kapoor P, Gonsalves WI, Hwa YL, Fonder A, Hobbs M, Kourelis T, Warsame R, Zeldenrust SR, Lust JA, Leung N, Go RS, Kyle RA, Rajkumar SV, Kumar SK. Mellors PW, et al. Among authors: hwa yl. Leuk Lymphoma. 2019 Dec;60(12):2960-2967. doi: 10.1080/10428194.2019.1613536. Epub 2019 May 16. Leuk Lymphoma. 2019. PMID: 31096812
Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy.
Gonsalves WI, Rajkumar SV, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Go RS, Leung N, Kapoor P, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Hwa YL, Kourelis TV, Kyle RA, Kumar SK. Gonsalves WI, et al. Among authors: hwa yl. Bone Marrow Transplant. 2016 Aug;51(8):1156-8. doi: 10.1038/bmt.2016.91. Epub 2016 Apr 11. Bone Marrow Transplant. 2016. PMID: 27064687 No abstract available.
Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy.
Nandakumar B, Kumar SK, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Siddiqui M, Go RS, Jevremovic D, Kyle RA, Gertz MA, Rajkumar SV, Gonsalves WI. Nandakumar B, et al. Among authors: hwa yl. Mayo Clin Proc. 2021 Mar;96(3):677-687. doi: 10.1016/j.mayocp.2020.06.060. Mayo Clin Proc. 2021. PMID: 33673918 Free PMC article.
122 results